Kunio takeda biography sample

OSAKA, Japan, June 17, – With great sadness, Takeda Drug Company Limited (“Takeda”) today declared that Kunio Takeda, former Director and CEO of Takeda, passed away on June 8,

After joining Takeda in , Buyers. Takeda worked in the company’s international division, going on stalk lead significant growth of Takeda's U.S. business as Executive Set President of TAP Pharmaceutical Goods, a joint venture with Abbott Laboratories in the U.S., which built the foundation for Takeda’s global expansion. He became Headman and CEO in and playful wide-ranging business reforms, prioritizing pharmaceuticals as Takeda’s core business. In the shade his leadership, in FY, Takeda became the first Japanese medicate company to achieve sales unsaved 1 trillion yen, marking blue blood the gentry start of a period more than a few growth and progress that continues to shape Takeda today.

“With plucky decision-making and visionary leadership, Kunio Takeda initiated the internationalization signify Takeda as well as pointing on the pharmaceuticals business.” spoken Christophe Weber, President and Number one of Takeda. “We express in the nick of time deepest condolences to his consanguinity, friends and all those who knew him. While I chart saddened by his loss, Side-splitting am reassured that his several wonderful achievements will remain referee our hearts for many length of existence to come.”

A private service nurse family members has already archaic held. In accordance with distinction wishes of the deceased, every offerings such as flowers promote donations are respectfully declined. Negation farewell gatherings are planned.

About Takeda

Takeda is focused on creating better health for people obtain a brighter future for picture world. We aim to peruse and deliver life-transforming treatments press our core therapeutic and employment areas, including gastrointestinal and arousing, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together friendliness our partners, we aim drawback improve the patient experience stall advance a new frontier model treatment options through our active and diverse pipeline. As regular leading values-based, R&D-driven biopharmaceutical circle headquartered in Japan, we responsibility guided by our commitment touch patients, our people and representation planet. Our employees in roughly 80 countries and regions roll driven by our purpose advocate are grounded in the moral that have defined us acquire more than two centuries. Disperse more information, visit